BioRem Inc. (CVE:BRM – Get Free Report) Director Derek Webb sold 28,700 shares of the company’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of C$3.82, for a total value of C$109,634.00. Following the completion of the sale, the director directly owned 362,370 shares in the company, valued at approximately C$1,384,253.40. The trade was a 7.34% decrease in their position.
Derek Webb also recently made the following trade(s):
- On Thursday, August 20th, Derek Webb sold 15,000 shares of BioRem stock. The shares were sold at an average price of C$3.82, for a total transaction of C$57,300.00.
BioRem Price Performance
Shares of CVE:BRM opened at C$3.62 on Friday. The company has a market cap of C$58.34 million, a P/E ratio of 10.77 and a beta of 0.81. The company has a quick ratio of 1.08, a current ratio of 2.04 and a debt-to-equity ratio of 14.17. BioRem Inc. has a 52 week low of C$1.87 and a 52 week high of C$3.95. The business has a fifty day simple moving average of C$3.35 and a 200-day simple moving average of C$3.03.
About BioRem
BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems.
Featured Stories
- Five stocks we like better than BioRem
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for BioRem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRem and related companies with MarketBeat.com's FREE daily email newsletter.
